亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Diffusively Permeable Monolithic Biomaterial with Embedded Mircofluidic Channels

詳細技術說明
This technology improves wound healing by use of biomaterial embedded with microfluidic networks to allow for active management of the chemistry within the biological matter.
*Abstract

Each year, more than seven million Americans suffer severe acute or chronic cutaneous wounds, many of which cannot be effectively treated with available wound healing methods. An important improvement to the wound healing process would be the ability to deliver and extract reagents on the micrometer scale over the macroscopic dimensions of a typical wound. This type of wound healing would require that a micrometer-scale vascular network be manufactured directly into a porous, biocompatible material.

 

We present a new technology that accomplishes the above-described improvement to wound healing. Cornell’s Vascular Biomaterial (VB) has been embedded with microfluidic networks to allow for active management of the chemistry within the biological matter. The networks can act as an artificial vascular system for synthetic materials, and the VB has potential to act as a scaffold for the more efficient healing of chronic wounds.

 

Potential Applications

Micrometer-scale control of mass-transfer in biomaterials has the potential to impact work in many fields, including:

  • Wound healing
  • Tissue culture
  • Tissue engineering
  • Drug delivery
  • Biological microfabrication

 

Advantages

Vascular Biomaterials offer unprecedented control of the chemical character of the interfaces between synthetic and biological systems. This ability to create artificial tissues that can be integrated into biological tissues addresses two important challenges in the field of wound healing:

1) Clinical treatment of severe cutaneous wounds due to burns or diabetes
2) In vitro modeling of the wound bed and the development of improved epidermal grafts

*Licensing
Carolyn A. Theodorecat42@cornell.edu(607) 254 4514
其他
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備